You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Drug Price Trends for NDC 70000-0546


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 70000-0546

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 70000-0546

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it's crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies a drug product. It consists of a labeler code, a product code, and a package code, configured in one of the following formats: 4-4-2, 5-3-2, or 5-4-1[1][4].

Identifying the Drug

The NDC 70000-0546 can be broken down as follows:

  • Labeler Code: The first segment identifies the firm that manufactures, repackages, or distributes the drug.
  • Product Code: The second segment identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment identifies the package size and type.

For the NDC 70000-0546, you would need to refer to the FDA's Drug Registration and Listing System (DRLS) or the electronic version (eDRLS) to get detailed information about the drug, including its labeler, product specifics, and packaging details[1].

Market Trends and Price Inflation

General Drug Price Trends

The pharmaceutical market is characterized by significant price inflation. According to recent projections, the overall drug price inflation rate for 2025 is estimated to be around 3.81%, driven in part by expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[5].

International Price Comparisons

Drug prices in the U.S. are notably higher than in other regions. For instance, in 2022, the average price per unit in the U.S. was 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world. This disparity is due to both higher prices for the same drugs and a drug mix that skews towards more expensive compounds in the U.S.[3].

Medicare Drug Price Negotiation

The Medicare Drug Price Negotiation Program, set to begin in January 2026, aims to reduce drug prices for Medicare Part D. Initial negotiations have resulted in discounts ranging from 38% to 79% compared to list prices. This program could significantly impact the pricing landscape for drugs, including those with high list price increases over recent years[2].

Specific Price Projections for NDC 70000-0546

To make accurate price projections for the drug with NDC 70000-0546, several factors need to be considered:

Historical Price Trends

  • If the drug has seen significant price increases in the past, similar to the nine drugs selected for Medicare negotiation that had list price increases of 20% to 55% between 2018 and 2023, it may continue to see inflationary pressures[2].

Market Demand and Competition

  • The demand for the drug, its therapeutic class, and the level of competition in the market can influence price stability or inflation.

Regulatory Changes

  • Initiatives like the Medicare Drug Price Negotiation Program could lead to reduced prices if the drug is selected for negotiation or if similar drugs are negotiated, setting a market precedent.

Provider and Payer Dynamics

  • The impact of expanding indications, as seen with medications like semaglutide, can drive up spending and potentially influence price increases[5].

Data Analysis and Calculation

To project prices, one would typically analyze historical pricing data, sales volumes, and market trends. Here’s a step-by-step approach:

  1. Historical Pricing Data:

    • Obtain the historical pricing data for the drug from sources like the FDA's NDC Directory, pharmacy retail data, or healthcare claims databases.
  2. Sales Volumes:

    • Calculate the average price per 30-day equivalent supply using data similar to that used in Medicare PDE (Prescription Drug Event) data, adjusting for volume and market share[2].
  3. Market Trends:

    • Analyze broader market trends, including overall drug price inflation rates and specific trends within the therapeutic class of the drug.
  4. Regulatory Impact:

    • Consider the potential impact of regulatory changes, such as the Medicare Drug Price Negotiation Program, on the pricing of similar drugs.

Example Calculation

Assuming the drug with NDC 70000-0546 has seen a historical price increase similar to other drugs in its class, and considering the projected 3.81% overall drug price inflation rate for 2025:

  • Current Price: If the current average price per 30-day equivalent supply is $100.
  • Projected Increase: Applying the 3.81% inflation rate, the projected price for 2025 would be $103.81.

Key Takeaways

  • NDC Importance: The NDC is crucial for identifying and tracking drug products, including their pricing and market trends.
  • Market Trends: Drug prices are generally increasing, with significant disparities between U.S. prices and those in other regions.
  • Regulatory Impact: Initiatives like the Medicare Drug Price Negotiation Program can significantly reduce prices for selected drugs.
  • Data Analysis: Accurate price projections require detailed historical data, sales volumes, and an understanding of market and regulatory trends.

FAQs

1. What is the National Drug Code (NDC) and how is it structured? The NDC is a unique, three-segment number identifying a drug product. It includes a labeler code, a product code, and a package code, configured in formats like 4-4-2, 5-3-2, or 5-4-1[1][4].

2. How do regulatory changes like the Medicare Drug Price Negotiation Program affect drug prices? These programs can lead to significant discounts, ranging from 38% to 79% compared to list prices, and set market precedents that could influence prices of similar drugs[2].

3. Why are drug prices in the U.S. higher than in other regions? Drug prices in the U.S. are higher due to both higher prices for the same drugs and a drug mix that skews towards more expensive compounds[3].

4. How can historical pricing data be used to project future prices? Historical pricing data can be analyzed to identify trends and combined with projected inflation rates and market trends to estimate future prices.

5. What role do expanding indications of previously approved medications play in drug price inflation? Expanding indications, such as those seen with semaglutide, can drive up spending and contribute to overall drug price inflation[5].

Sources

  1. FDA: National Drug Code Database Background Information.
  2. ASPE: Medicare Drug Price Negotiation Program.
  3. ASPE: International Market Size and Prices.
  4. YouTube: NDC Directory (March 2015).
  5. Vizient: Vizient projects drug price inflation at 3.81%.
Last updated: 2024-12-31

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.